News

CaridianBCT Revolutionizes the Cell Thearpy

Thursday, March 31, 2011

CARIDIANBCT REVOLUTIONIZES THE CELL THERAPY INDUSTRY WITH NEW CELL EXPANSION PRODUCT 

CO-LABS Economic Impact Study

Wednesday, March 30, 2011

NEW STUDY SHOWS FEDERAL LABS INJECTED $1.5 BILLION INTO STATE’S ECONOMY AND SUPPORTED 16,000 JOBS IN 2010 

Sharklet Technologies Awarded $1.2 Million

Tuesday, March 29, 2011

DENVER - Sharklet Technologies, Inc. today announced that it has been awarded a $1.2 million Small Business Innovation Research (SBIR) Phase II grant by the National Institutes of Health (NIH) / National Institute of Diabetes and Digestive and Kidney Diseases* to continue its development of a urinary Foley catheter with the Sharklet™ micro-pattern that inhibits bacterial growth on the surface of the catheter. . today announced that it has been awarded a $1.2 million Small Business Innovation Research (SBIR) Phase II grant by the National Institutes of Health (NIH) / National Institute of Diabetes and Digestive and Kidney Diseases* to continue its development of a urinary Foley catheter with the Sharklet™ micro-pattern that inhibits bacterial growth on the surface of the catheter.  

CU announces $3.5 million in gifts from ConocoPhillips to biotech building

Tuesday, March 29, 2011

Houston-based energy firm ConocoPhillips has made a major gift toward the University of Colorado Boulder's Jennie Smoly Caruthers Biotechnology Building to bring together world-class scientists and engineers working toward solutions in fields such as medicine and energy.  

Annual DSST Public Schools Celebration

Monday, March 28, 2011

Slice of Pi 

Review of the Second Tier of Biotechnology Clusters in the US

Monday, March 28, 2011

GEN 

Creating new funding in a post-recession market

Friday, March 25, 2011
Premium content from Denver Business Journal - by Heather Draper  
Continue Reading

BiOptix Announces Closing of $9M Series B Financing

Thursday, March 24, 2011

Boulder, Colorado. BiOptix Diagnostics, Inc., a Boulder, CO based analytical instrumentation firm, announced today the closing of $9M Series B financing. The $9M round was led by The Russian Corporation for Nanotechnologies (“RUSNANO”) which was joined in the round by Boulder Ventures Ltd., Peierls Foundation, and several private investors.

“RUSNANO has collaborated with high technology companies in the USA before, but this is the first time we have invested directly into an American legal entity. We are proud to be a part of such a great innovation story. I believe that products of BiOptix could open new horizons for development of new promising drugs”, underscores managing director of RUSNANO Evgeny Evdokimov.

http://www.bioptixinc.com/wp-content/uploads/2011/01/110324_BiOptix_Series_B_press_release.pdf

 

 
Continue Reading

LABS, Inc. Announces Alliance with Ambry Genetics

Thursday, March 24, 2011

LABS, Inc. Announces Alliance with Ambry Genetics to Expand Testing Solutions for the Reproductive Health Industry

 
Continue Reading

The Search for Ingredients to Replicate Silicon Valley

Tuesday, March 22, 2011

By STEVEN M. DAVIDOFF